Level I | Good quality evidence |
Systematic review of RCTs with consistent findings High quality individual RCT |
Level II |
Limited quality patient orientated evidence |
Systematic review of lower quality studies or studies with inconsistent findings Low quality clinical trial Cohort studies Case-control studies |
Level III | Other |
Consensus guidelines, extrapolations from bench research, usual practice, opinion, disease-oriented evidence (intermediate or physiologic outcomes only), or case series |
[19] Activated charcoal (single dose): National Department of Health: Affordable Medicines, EDP-Adult Hospital level. Medicine Review: Single dose activated charcoal for poisonings, May 2019. http://www.health.gov.za/
Activated charcoal (single dose): Chyka PA, Seger D; American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. Position statement: single-dose activated charcoal. J Toxicol Clin Toxicol 1997;35(7):721-41. https://www.ncbi.nlm.nih.gov/pubmed/15822758
Activated charcoal (single dose): Rosenberg J, Benowitz NL, Pond S. Pharmacokinetics of drug overdose. Clin Pharmacokinet 1981; 6:161– 192. https://www.ncbi.nlm.nih.gov/pubmed/7016383
Activated charcoal (single dose): Yeates PJA, Thomas SHL. Effectiveness of delayed activated charcoal administration in simulated paracetamol (acetaminophen) overdose. Br J Clin Pharmacol 2000; 49:11–14. https://www.ncbi.nlm.nih.gov/pubmed/7016383
Activated charcoal (single dose): Laine K, Kivisto¨ KT, Pelttari S, Neuvonen PJ. The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration. Pharmacol Toxicol 1996; 79:270– 273. https://www.ncbi.nlm.nih.gov/pubmed/8936562
Activated charcoal (single dose): Laine K, Kivisto¨ KT, Neuvonen PJ. Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil. J Toxicol Clin Toxicol 1997; 35:263–268. https://www.ncbi.nlm.nih.gov/pubmed/9140320
Activated charcoal (single dose): Laine K, Kivisto¨ KT, Ojala-Karlsson P, Neuvonen PJ. Effect of activated charcoal on the pharmacokinetics of pholcodine, with special reference to delayed charcoal ingestion. Ther Drug Monit 1997; 19:46– 50. https://www.ncbi.nlm.nih.gov/pubmed/9029746
Activated charcoal (single dose): Green R, Grierson R, Sitar DS, Tenenbein M. How long after drug ingestion is activated charcoal still effective? J Toxicol Clin Toxicol 2001; 39:601– 605. https://www.ncbi.nlm.nih.gov/pubmed/11762668